YBX1 and glioblastoma: YBX1 is highly expressed in a variety of malignancies including GBM; in various types of cancer, YBX1 overexpression has been associated with tumor cell proliferation, invasion, apoptotic resistance, drug resistance, and poor prognosis [14, 20–22].